Literature DB >> 8072086

Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma.

P Karling1, M Hammar, E Varenhorst.   

Abstract

A total of 77 men with prostatic carcinoma treated with orchiectomy or a gonadotropin releasing hormone analogue before September 1987 underwent evaluation by a questionnaire regarding vasomotor symptoms. Answers were received from 84% of the patients. Of 63 patients 43 (68%) reported hot flushes during treatment, while 30 (48%) still had flushes 5 years after treatment. Of the latter 30 patients 28 (median 7.6 years after treatment) had vasomotor symptoms at the time of the study. Only 13 of 43 men with vasomotor symptoms after the start of treatment had relief 5 years later. At the time of the study 13 of 30 patients (more than 40%) still had flushes 8 years after castration. Most men reported that the flushes presently had the same frequency and duration as when they started therapy. Contrary to the general belief that the symptoms disappear with time, our study highlighted a long persistence of hot flushes after castration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8072086     DOI: 10.1016/s0022-5347(17)32530-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  Androgen deprivation and thromboembolic events in men with prostate cancer.

Authors:  Behfar Ehdaie; Coral L Atoria; Amit Gupta; Andrew Feifer; William T Lowrance; Michael J Morris; Peter T Scardino; James A Eastham; Elena B Elkin
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

2.  Venlafaxine for the treatment of hormonal therapy-induced hot flashes in a male patient.

Authors:  Harmit Singh; Ashish Sharma
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 3.  Androgen deprivation therapy-associated vasomotor symptoms.

Authors:  Jason M Jones; Manish Kohli; Charles L Loprinzi
Journal:  Asian J Androl       Date:  2012-01-30       Impact factor: 3.285

4.  Effects of Testosterone and Estradiol Deficiency on Vasomotor Symptoms in Hypogonadal Men.

Authors:  Alexander P Taylor; Hang Lee; Matthew L Webb; Hadine Joffe; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2016-06-14       Impact factor: 5.958

5.  Advanced prostate cancer: an update.

Authors:  A Ziada; E D Crawford; F H Schröeder; M E Gleave; P D Miller; M B Garnick
Journal:  Rev Urol       Date:  2000

6.  Quality of life in low-income patients with metastatic prostate cancer: divergent and convergent validity of three instruments.

Authors:  L K Sharp; S J Knight; R Nadler; M Albers; E Moran; T Kuzel; R Sharifi; C Bennett
Journal:  Qual Life Res       Date:  1999-08       Impact factor: 4.147

Review 7.  Management of complications of androgen deprivation therapy in the older man.

Authors:  Supriya G Mohile; Karen Mustian; Kathryn Bylow; William Hall; William Dale
Journal:  Crit Rev Oncol Hematol       Date:  2008-10-25       Impact factor: 6.312

8.  Estrogenic side effects of androgen deprivation therapy.

Authors:  Theresa A Guise; Michael G Oefelein; James A Eastham; Michael S Cookson; Celestia S Higano; Matthew Raymond Smith
Journal:  Rev Urol       Date:  2007

Review 9.  How long do the effects of acupuncture on hot flashes persist in cancer patients?

Authors:  Jessica W Frisk; Mats L Hammar; Martin Ingvar; Anna-Clara E Spetz Holm
Journal:  Support Care Cancer       Date:  2014-01-30       Impact factor: 3.603

10.  A Neural Circuit Underlying the Generation of Hot Flushes.

Authors:  Stephanie L Padilla; Christopher W Johnson; Forrest D Barker; Michael A Patterson; Richard D Palmiter
Journal:  Cell Rep       Date:  2018-07-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.